The US government will pay Fresenius $2.6 billion for dialysis services

The US government awarded a $2.6 billion contract to Fresenius Medical Care Holdings Inc. for national dialysis services. This means Fresenius will continue to be a primary provider of dialysis for government-covered patients.

This contract ensures a steady revenue stream for Fresenius, a major player in the dialysis market. It also locks in a significant portion of government healthcare spending for kidney care with a single provider. This kind of large, long-term contract shapes the market for medical services for years.